CTNM
Contineum Therapeutics, Inc.$14.48-0.09 (-0.62%)Prev Close$14.57·MCap$577.6M·P/E—·Vol128.2K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
23
$1.92M
◆
Net Activity
Net Seller
$1.92M
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Contineum Therapeutics, Inc. (CTNM) has been exclusively selling, with 0 insider purchases totaling $0.00 and 23 insider sales totaling $1.92M. The most recent insider transaction was by Lorrain Daniel S. (officer: Chief Scientific Officer), who sold $400.00 worth of shares on Jul 10, 2026. Contineum Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $577.6M.
CTNM Insider Trading Activity
CTNM Insider Buying Activity
The following table shows recent insider purchases of Contineum Therapeutics, Inc. (CTNM) stock reported via SEC Form 4 filings.
No insider buying activity found for CTNM in the last 12 months.
CTNM Insider Selling Activity
The following table shows recent insider sales of Contineum Therapeutics, Inc. (CTNM) stock reported via SEC Form 4 filings.